James George Chopas is VP/Chief Accounting Officer of Apellis Pharmaceuticals, Inc.. Currently has a direct ownership of 53,468 shares of APLS, which is worth approximately $1.11 Million. The most recent transaction as insider was on Aug 30, 2022, when has been sold 558 shares (Common Stock) at a price of $58.84 per share, resulting in proceeds of $32,833. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 53.5K
1.36% 3M change
40.19% 12M change
Total Value Held $1.11 Million

James George Chopas Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 30 2022
SELL
Payment of exercise price or tax liability
$32,833 $58.84 p/Share
558 Reduced 2.92%
18,581 Common Stock
Jan 21 2022
BUY
Grant, award, or other acquisition
-
6,974 Added 31.09%
15,456 Common Stock
Oct 20 2021
BUY
Grant, award, or other acquisition
-
882 Added 9.42%
8,482 Common Stock
Aug 30 2021
BUY
Grant, award, or other acquisition
-
7,600 Added 50.0%
7,600 Common Stock

Also insider at

RDUS
Radius Health, Inc. Healthcare
JGC

James George Chopas

VP/Chief Accounting Officer
Waltham, MA

Track Institutional and Insider Activities on APLS

Follow Apellis Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APLS shares.

Notify only if

Insider Trading

Get notified when an Apellis Pharmaceuticals, Inc. insider buys or sells APLS shares.

Notify only if

News

Receive news related to Apellis Pharmaceuticals, Inc.

Track Activities on APLS